Skip to main navigation
About Us
Our Therapy
Clinical and Scientific Publications
Our Products
HEPZATO KIT™
CHEMOSAT®
Clinical Trials
Investors
News
Contact
Careers
Overview
News & Events
Press Releases
Events & Presentations
Financials
Annual Reports & Proxy
SEC Filings
Stock Info
Governance
Documents & Charters
Management
Board of Directors
Committee Composition
IR Resources
FAQs
Analyst Coverage
Email Alerts
Search Investor Relations
Investor Menu
Now Live on OncLive: All 7 ESMO 2025 Review Episodes
Key Updates in Metastatic Uveal Melanoma
Watch the Full Series →
Event Details
Delcath Systems Fourth Quarter 2025 Earnings Call
February 26, 2026
8:30 AM EST
Listen to Webcast
Search Investors
Search this site
Submit
